Microcystin-LR promotes epithelial-mesenchymal transition in colorectal cancer cells through PI3-K/AKT and SMAD2.
暂无分享,去创建一个
Lihua Zhou | W. Qin | Mengli Yang | Yande Ren | Meng Chen | Ting Wang | Qiangqiang Zhu
[1] C. Miao,et al. Microcystin‐LR promotes migration and invasion of colorectal cancer through matrix metalloproteinase‐13 up‐regulation , 2016, Molecular carcinogenesis.
[2] Yaoping Li,et al. Overexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-β/Smad2/3 signaling. , 2015, The international journal of biochemistry & cell biology.
[3] P. Chueh,et al. Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways , 2015, PloS one.
[4] Yongbing Chen,et al. High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer , 2014, World Journal of Surgical Oncology.
[5] X. Sun,et al. COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1 , 2014, British Journal of Cancer.
[6] Timo H. J. Niedermeyer,et al. Selectivity and Potency of Microcystin Congeners against OATP1B1 and OATP1B3 Expressing Cancer Cells , 2014, PloS one.
[7] J. Yook,et al. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells. , 2014, International journal of oncology.
[8] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[9] Z. Fu,et al. Promotion of melanoma cell invasion and tumor metastasis by microcystin-LR via phosphatidylinositol 3-kinase/AKT pathway. , 2013, Environmental science & technology.
[10] D. Cui,et al. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. , 2013, International journal of oncology.
[11] Daniel J. Devine,et al. Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling , 2013, Oncogene.
[12] Eun-Kyoung Breuer,et al. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. , 2013, Cancer letters.
[13] Z. Fu,et al. Microcystin-LR promotes melanoma cell invasion and enhances matrix metalloproteinase-2/-9 expression mediated by NF-κB activation. , 2012, Environmental science & technology.
[14] J. Foidart,et al. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer , 2012, Oncogene.
[15] Ling Xia,et al. Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells , 2012, Cancer medicine.
[16] C. Rüegg,et al. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. , 2012, Cancer Discovery.
[17] Y. Li,et al. NF-κB mediates the induction of Fas receptor and Fas ligand by microcystin-LR in HepG2 cells , 2011, Molecular and Cellular Biochemistry.
[18] Liuyan Yang,et al. Endoplasmic reticulum stress in murine liver and kidney exposed to microcystin-LR. , 2010, Toxicon : official journal of the International Society on Toxinology.
[19] T. Furukawa,et al. p53 Plays an Important Role in Cell Fate Determination after Exposure to Microcystin-LR , 2010, Environmental health perspectives.
[20] V. Vasconcelos,et al. Molecular Mechanisms of Microcystin Toxicity in Animal Cells , 2010, International journal of molecular sciences.
[21] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[22] Gerhard Christofori,et al. EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.
[23] O. De Wever,et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[24] V. Ellenrieder. TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer. , 2008, Anticancer research.
[25] M. Filipič,et al. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis. , 2008, Toxicon : official journal of the International Society on Toxinology.
[26] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.
[28] T. Fukushima,et al. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer. , 2003, Journal of experimental & clinical cancer research : CR.
[29] Kun Chen,et al. Relationship between microcystin in drinking water and colorectal cancer. , 2002, Biomedical and environmental sciences : BES.
[30] A. G. Herreros,et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.
[31] Francisco Portillo,et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.
[32] H. Fujiki,et al. Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development. , 2011, Anti-cancer agents in medicinal chemistry.
[33] T. Rohrlack,et al. Microcystin concentrations in Nile tilapia (Oreochromis niloticus) caught from Murchison Bay, Lake Victoria and Lake Mburo: Uganda , 2009, Hydrobiologia.